Edition:
United States

Stemline Therapeutics Inc (STML.OQ)

STML.OQ on NASDAQ Stock Exchange Capital Market

15.25USD
12:05pm EDT
Change (% chg)

$0.05 (+0.33%)
Prev Close
$15.20
Open
$15.30
Day's High
$15.60
Day's Low
$15.10
Volume
7,655
Avg. Vol
58,983
52-wk High
$20.55
52-wk Low
$7.30

Select another date:

Wed, May 9 2018

BRIEF-Stemline Therapeutics Reports Q1 Loss Per Share $0.69

* STEMLINE THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

Stemline Therapeutics wins dismissal of shareholder lawsuit

A federal judge has dismissed a lawsuit accusing Stemline Therapeutics Inc of misleading investors about its ability to address the risk of a fatal side effect associated with a drug it was developing to treat certain blood-related cancers.

BRIEF-Stemline Therapeutics Inc - Co Launched An At-Market Offering Of Up To $50 Million Worth Of Shares

* STEMLINE THERAPEUTICS INC - ‍ON MARCH 16, 2018, CO LAUNCHED AN AT--MARKET OFFERING OF UP TO $50 MILLION WORTH OF SHARES OF COMPANY'S COMMON STOCK​ Source text (http://bit.ly/2HHHaYN) Further company coverage: (Reuters.Brief@thomsonreuters.com)

BRIEF-Stemline Therapeutics Q4 Loss Per Share $0.93

* STEMLINE THERAPEUTICS REPORTS FOURTH QUARTER 2017 FINANCIAL RESULTS

Select another date: